8:00 AM – Breakfast and Networking
8:30 AM – Opening Remarks – Rebecca Phaeton, M.D. & Nadine Hempel, Ph.D.
8:40 AM – Dr. June Y. Hou, M.D., Columbia University: “Insights into the molecular building blocks of ovarian cancer: Exploiting new opportunities and strategies”
9:20 AM – Dr. George-Lucian Moldovan, Ph.D., Penn State College of Medicine: “Novel mechanisms regulating the response of BRCA-mutant tumors to genotoxic chemotherapy”
10:00 AM – 1 min Elevator pitch Presentations
10:15 AM – Poster Session and Coffee Break
10:40 AM – Dr. Katherine Aird, Ph.D., Penn State College of Medicine: “Exploiting metabolic pathways to sensitize ovarian cancers to PARP inhibitors”
11:20 AM – Dr. Dineo Khabele, M.D., The University of Kansas: “Expanding PARP Inhibitor Efficacy in Ovarian Cancer with Epigenetic Drugs”
12:00 PM – Lunch & Poster Prize Announcement – Carol Weisman, Ph.D. (Penn State Center for Women’s Health Research)
12:20 PM – Molecular Tumor Board – Interactive Session with Audience and Plenary Session Speakers. Moderators: Joshua Warrick, M.D., and Joshua Kesterson, M.D.
Date and Time: May 8, 2019, 8AM – 1PM
Venue: University Conference Center, Penn State College of Medicine, Hershey PA